Dr. Benjamin Oshrine
Claim this profileJohns Hopkins All Children's Hospital
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
7 reported clinical trials
12 drugs studied
Area of expertise
1Leukemia
CD19 positive
HLA negative
RB1 positive
2Lymphoblastic Leukemia-Lymphoma
CD19 positive
Affiliated Hospitals
Clinical Trials Benjamin Oshrine is currently running
Reduced Intensity BMT
for Solid Cancer
The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and shortened duration tacrolimus is safe and feasible for patients with very high-risk solid tumors.
Recruiting1 award Phase 228 criteria
Vorinostat + Azacitidine
for Acute Myeloid Leukemia
The objective of this study is to evaluate the maximum tolerated (MTD) of vorinostat used in combination with low-dose azacitidine after allogeneic hematopoietic cell transplantation (alloHCT) for prevention of relapse of childhood myeloid malignancies.
Recruiting3 awards Phase 17 criteria
More about Benjamin Oshrine
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Benjamin Oshrine has experience with
- Tisagenlecleucel
- Vorinostat
- Azacitidine Injection
- Lactobacillus Plantarum
- Nivolumab
- Melphalan
Breakdown of trials Benjamin Oshrine has run
Leukemia
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Acute Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Oshrine specialize in?
Benjamin Oshrine focuses on Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Leukemia has involved CD19 positive patients, or patients who are HLA negative.
Is Benjamin Oshrine currently recruiting for clinical trials?
Yes, Benjamin Oshrine is currently recruiting for 4 clinical trials in Saint Petersburg Florida. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Oshrine has studied deeply?
Yes, Benjamin Oshrine has studied treatments such as Tisagenlecleucel, Vorinostat, Azacitidine Injection.
What is the best way to schedule an appointment with Benjamin Oshrine?
Apply for one of the trials that Benjamin Oshrine is conducting.
What is the office address of Benjamin Oshrine?
The office of Benjamin Oshrine is located at: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida 33701 United States. This is the address for their practice at the Johns Hopkins All Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.